Candy Swift

Joined: December 11th, 2015
Articles Posted: 9

Articles

Published 4 Years Ago
Different formats of Bispecific Antibodies Redirect T Cells to Target Tumors
Therapeutic antibodies have become the main force for the treatment of various diseases, such as cancers, autoimmune diseases, inflammations.

Published 4 Years Ago
CAR-NK Cell Therapy: Safer Choice to Treat Tumors
Chimeric antigen receptor T cell (CAR-T) therapy that use genetically modified T cells to kill cancer cells has proven to be a promising method to tre

Published 4 Years Ago
Four Monoclonal Antibodies for Treatment of Non-Hodgkin's Lymphoma
Lymphoma is a tumor that develops on lymphocytes, divided into Hodgkin's Lymphoma (HL) and Non-Hodgkin's Lymphoma (NHL) according to pathological.

Published 4 Years Ago
Seahle Genetics’ Innovative Antibody-drug Conjugate SGN-CD48A Entered Clinical D
SGN-CD48A is an experimental antibody drug conjugate (ADC) targeting the CD48 protein, which is highly expressed on the surface of MM cells.

Published 4 Years Ago
How to Improve Cancer Vaccines Research Efficiently
How to Improve Cancer Vaccines Research Efficiently

Published 4 Years Ago
Two Kinds of Common Vaccine Adjuvants
Adjuvant, also known as immunomodulator or immune enhancer, is an additive of a vaccine.

Published 5 Years Ago
Overview on Current Antibody-drug Conjugate Technology Providers
Overview on Current Antibody-drug Conjugate Technology Providers

Published 8 Years Ago
The Latest Research Progress in ScFv
Recently, some scientists have raised a idea that scFv shouldn’t focus on the traditional antibody because modern new drugs require more efficient antibodies. The latest research progress in scFv has indicated there are two new types, namely the